Drug Discovery 기술

The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.

The bioanalytical instruments market for drug discovery technologies is expected to grow from $30.0 billion in 2024 and is projected to reach $50.3 billion by the end of 2029, at a CAGR of 10.9% during the forecast period of 2024 to 2029.

The high-throughput screening market for drug discovery technologies is expected to grow from $25.0 billion in 2024 and is projected to reach $43.9 billion by the end of 2029, at a CAGR of 11.9% during the forecast period of 2024 to 2029.

Report Scope:

This report provides detailed information on the drug discovery technologies market. This report analyzes the market trends of drug discovery technologies with data from 2023, estimates from 2024, projections of compound annual growth rates (CAGRs) through 2029 (forecast period 2024-2029), and regional markets of drug discovery technologies. This report highlights drug discovery technologies' current and future market potential and gives a detailed analysis of the competitive environment. The report covers regulatory scenarios, drivers, restraints, and opportunities. This report also covers market projections for 2029 and the market share for key market players.

The market scope in this report is segmented into technologies and applications. Based on technologies, this report covers high-throughput screening (HTS), bioanalytical instruments, cell-based assays and reagents, genomics, bioinformatics, proteomics, and others, such as combinatorial chemistry, metabolomics, nanotechnology, and system biology. These technologies are further classified into subcategories for this report. The market is segmented based on application to oncology, cardiovascular diseases, neurodegenerative diseases, immunological diseases, and others.

The market has been segmented into North America, Europe, Asia-Pacific, and other world regions. The regional segment covers a detailed analysis of major countries such as the U.S., Canada, Germany, the U.K., Italy, Spain, France, Japan, China, South Korea, Australia, and India. For market estimates, data is provided for 2023, with forecasts for 2024 and projections for 2029.

The report's goals include:

• Analyzing technologies and applications.
• Analyzing global market size and segmentation.
• Identifying market constraints and drivers.
• Providing detailed market forecasts through 2029.
• Assessing market shares, competitiveness, and industry structure.
• Identifying potential long-term impacts on the drug discovery technologies market.

Report Includes:

• 104 data tables and 34 additional tables
• An analysis of the current and future global markets for drug discovery technologies
• Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
• Estimates of the market size and revenue forecasts for the global market for drug discovery technologies, with market share analysis by therapeutics, application, end user and region
• Discussion of bioinformatics as a platform for drug discovery
• A comparison between proteomics and genomics drug discovery technology
• Comparative assessment of pharmacokinetics and pharmacodynamics, and classification of the techniques used in drug discovery
• Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
• Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes
• Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
• Profiles of the leading companies, including Thermo Fisher Scientific Inc., Danaher Corp., Agilent Technologies Inc., Illumina, and Charles River Laboratories.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of the Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Porter's Five Forces Analysis
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential for New Entrants
• Threat of Substitutes
• Competitiveness in the Industry

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• High-Content Screening (HCS) Techniques in Drug Discovery
• Technological Advances
• Demand for Personalized Medicine
• Rising Prevalence of Chronic and Immunological Diseases
• Growing Elderly Population
• Availability of Research Funds
• Market Restraints
• Cost of the Drug Discovery Process and Instruments
• Stringent Regulations
• Better Understanding of Molecular Mechanisms
• Market Opportunities
• Potential for AI in Drug Discovery

Chapter 4 Emerging Technologies

• Overview
• AI

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Global Market for Drug Discovery Technologies, by Technology
• Global Market Forecast
• High-Throughput Screening (HTS)
• Bioanalytical Instruments
• Genomics
• Proteomics
• Cell-Based Assays and Reagents
• Bioinformatics
• Other Technologies
• Market for Drug Discovery Technologies, by Disease Application
• Global Market Size and Forecast
• Oncology
• Cardiology
• Neurodegenerative Diseases
• Immunological Diseases
• Other Diseases
• Global Market for Drug Discovery Technologies, by End User
• Global Market Size and Forecast
• Biopharmaceutical Companies
• Research and Academia
• Contract Research Organizations (CROs)
• Geographic Breakdown
• Global Market for Drug Discovery Technologies, by Region
• Global Market Size and Forecast
• North America
• Europe
• Asia-Pacific
• Rest of World

Chapter 6 Competitive Intelligence

• Competitive Landscape
• Analysis of Companies' Market Shares
• SWOT Analysis
• Strengths
• Challenges
• Opportunities
• Threats

Chapter 7 Sustainability in the Drug Delivery Technologies Market: An ESG Perspective

• Introduction to ESG
• Sustainability in the Drug Discovery Technologies Industry
• ESG Perspective
• Environmental Impact
• Social Impact
• Governance Impact

Chapter 8 Appendix

• Methodology
• Abbreviations
• Sources
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• BIO-RAD LABORATORIES INC.
• BRUKER
• CHARLES RIVER LABORATORIES
• DANAHER CORP.
• ILLUMINA INC.
• PROMEGA CORP.
• QIAGEN
• REVVITY
• THERMO FISHER SCIENTIFIC INC.